A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer (CELLO-1)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04179864 |
Recruitment Status :
Active, not recruiting
First Posted : November 27, 2019
Last Update Posted : April 29, 2024
|
Sponsor:
Epizyme, Inc.
Information provided by (Responsible Party):
Ipsen ( Epizyme, Inc. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | June 28, 2024 |
Estimated Study Completion Date : | June 28, 2024 |